Retell J, Cameron J, Aitken J, Youl P, Pyke C, Dunn J
Breast Cancer Res Treat. 2023; 203(3):575-586.
PMID: 37930491
PMC: 10805972.
DOI: 10.1007/s10549-023-07134-4.
Ruco A, Groome P, McBride M, Decker K, Grunfeld E, Jiang L
Cancers (Basel). 2023; 15(2).
PMID: 36672357
PMC: 9857089.
DOI: 10.3390/cancers15020404.
Afaya A, Ramazanu S, Bolarinwa O, Yakong V, Afaya R, Aboagye R
BMC Health Serv Res. 2022; 22(1):1601.
PMID: 36587198
PMC: 9805268.
DOI: 10.1186/s12913-022-08927-x.
Mohd Mujar N, Dahlui M, Emran N, Hadi I, Yan Y, Arulanantham S
JCO Glob Oncol. 2022; 8:e2100250.
PMID: 35286134
PMC: 8932493.
DOI: 10.1200/GO.21.00250.
Williams F
J Cancer Biol Res. 2021; 3(4).
PMID: 34258389
PMC: 8274552.
Health system factors that influence diagnostic and treatment intervals in women with breast cancer in sub-Saharan Africa: a systematic review.
Gbenonsi G, Boucham M, Belrhiti Z, Nejjari C, Huybrechts I, Khalis M
BMC Public Health. 2021; 21(1):1325.
PMID: 34229634
PMC: 8259007.
DOI: 10.1186/s12889-021-11296-5.
Diagnostic interval for non-screening patients undergoing mammography during the COVID-19 pandemic.
Crivellaro P, Tafur M, George R, Muradali D
Eur Radiol. 2021; 32(1):613-620.
PMID: 34143286
PMC: 8211559.
DOI: 10.1007/s00330-021-08117-z.
Delayed or failure to follow-up abnormal breast cancer screening mammograms in primary care: a systematic review.
Reece J, Neal E, Nguyen P, McIntosh J, Emery J
BMC Cancer. 2021; 21(1):373.
PMID: 33827476
PMC: 8028768.
DOI: 10.1186/s12885-021-08100-3.
Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women.
Emerson M, Golightly Y, Aiello A, Reeder-Hayes K, Tan X, Maduekwe U
Cancer. 2020; 126(22):4957-4966.
PMID: 32954493
PMC: 7789230.
DOI: 10.1002/cncr.33121.
Determining the Cancer Diagnostic Interval Using Administrative Health Care Data in a Breast Cancer Cohort.
Groome P, Webber C, Whitehead M, Moineddin R, Grunfeld E, Eisen A
JCO Clin Cancer Inform. 2019; 3:1-10.
PMID: 31112418
PMC: 6874005.
DOI: 10.1200/CCI.18.00131.
Comparison of wait times across the breast cancer treatment pathway among screened women undergoing organized breast assessment versus usual care.
Blackmore K, Weerasinghe A, Holloway C, Majpruz V, Mirea L, OMalley F
Can J Public Health. 2019; 110(5):595-605.
PMID: 31037608
PMC: 6964595.
DOI: 10.17269/s41997-019-00210-7.
Mammography facilities serving vulnerable women have longer follow-up times.
Karliner L, Kaplan C, Livaudais-Toman J, Kerlikowske K
Health Serv Res. 2018; 54 Suppl 1:226-233.
PMID: 30394526
PMC: 6341204.
DOI: 10.1111/1475-6773.13083.
Influence of the time interval from diagnosis to treatment on survival for early-stage liver cancer.
Tsai W, Kung P, Wang Y, Kuo W, Li Y
PLoS One. 2018; 13(6):e0199532.
PMID: 29933395
PMC: 6014663.
DOI: 10.1371/journal.pone.0199532.
Provider Perspectives of the Complexities of Follow-Up of Abnormal Mammographic Findings.
Fair A, Beckwitt A, Wujcik D, Wilkins C, Halmon U, Disher A
J Am Coll Radiol. 2017; 14(9):1190-1193.
PMID: 28579195
PMC: 5653250.
DOI: 10.1016/j.jacr.2017.04.013.
Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care.
Chiarelli A, Muradali D, Blackmore K, Smith C, Mirea L, Majpruz V
Br J Cancer. 2017; 116(10):1254-1263.
PMID: 28359079
PMC: 5482732.
DOI: 10.1038/bjc.2017.87.
Insurance-Based Differences in Time to Diagnostic Follow-up after Positive Screening Mammography.
Durham D, Robinson W, Lee S, Wheeler S, Reeder-Hayes K, Bowling J
Cancer Epidemiol Biomarkers Prev. 2016; 25(11):1474-1482.
PMID: 27803069
PMC: 5115635.
DOI: 10.1158/1055-9965.EPI-16-0148.
Providers' Views on a Community-Wide Patient Navigation Program: Implications for Dissemination and Future Implementation.
de la Riva E, Hajjar N, Tom L, Phillips S, Dong X, Simon M
Health Promot Pract. 2016; 17(3):382-90.
PMID: 27009130
PMC: 5600160.
DOI: 10.1177/1524839916628865.
The effects of navigation and types of neighborhoods on timely follow-up of abnormal mammogram among black women.
Kim S, Molina Y, Glassgow A, Berrios N, Guadamuz J, Calhoun E
Med Res Arch. 2016; 2015(3).
PMID: 26949738
PMC: 4775089.
DOI: 10.18103/mra.v0i3.111.
Paths to health equity: Local area variation in progress toward eliminating breast cancer mortality disparities, 1990-2009.
Rust G, Zhang S, Malhotra K, Reese L, McRoy L, Baltrus P
Cancer. 2015; 121(16):2765-74.
PMID: 25906833
PMC: 4540479.
DOI: 10.1002/cncr.29405.
Evaluating a bilingual patient navigation program for uninsured women with abnormal screening tests for breast and cervical cancer: implications for future navigator research.
Simon M, Tom L, Nonzee N, Murphy K, Endress R, Dong X
Am J Public Health. 2015; 105(5):e87-94.
PMID: 25713942
PMC: 4386517.
DOI: 10.2105/AJPH.2014.302341.